Technology
Why China’s biotech rise is harder to contain than AI
China is emerging as a biotech powerhouse, but its rise is entwined with US drugmakers through research, licensing and supply chains, making decoupling far more difficult than in AI. Academic Chen Xiangming and biopharma industry practitioner Leon Tang analyse the situation.
Chen Xiangming, Leon Tang
05 Aug 2026